1. FDA Safety Communication: Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. Issued on 13 July 2011. http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm . Accessed on 12 June 2012
2. Dangerous medical devices: most medical implants have never been tested for safety. Consumer Reports Magazine, May 2012. Accessed on 9 July 2012 at: http://www.consumerreports.org/cro/magazine/2012/04/cr-investigates-dangerous-medical-devices/index.htm
3. FDA Executive Summary: Surgical mesh for the treatment of women with pelvic organ prolapse and stress urinary incontinence, 8–9 September 2011. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM270402.pdf . Accessed on 12 June 2012
4. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506
5. Altman D, Vayrynen T, Engh ME, Axelsen S, Falconer C (2011) Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med 364(19):1826–1836